Harel Insurance Investments & Financial Services’s Kite Pharma, Inc. KITE Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-520	Closed	-$29K	–	480
2016 Q3	$29K	Hold	520	–	–	﹤0.01%	272
2016 Q2	$26K	Sell	520 -110	-17%	-$5.41K	﹤0.01%	433
2016 Q1	$29K	Sell	630 -200	-24%	-$9.69K	﹤0.01%	249
2015 Q4	$51K	Buy	+830	New	+$58.4K	0.01%	198

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Harel Insurance Investments & Financial Services's KITE Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 520 shares — an estimated $29K sold.

Harel Insurance Investments & Financial Services first reported a position in KITE in Q4 2015 and held it in 4 quarters. The position peaked at $51K in Q4 2015. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Harel Insurance Investments & Financial Services reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 520 Kite Pharma, Inc. shares in Q4 2016, an estimated $29K.
Harel Insurance Investments & Financial Services first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 4 quarters.
Harel Insurance Investments & Financial Services's Kite Pharma, Inc. position peaked at $51K in Q4 2015.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.